Naldemedine: A New Option for OIBD

Naldemedine: A New Option for OIBD

Flaminia Coluzzi,1 Maria Sole Scerpa,1 Joseph Pergolizzi2 1Department of Medical and Surgical Sciences and Biotechnologies, Sapienza University of Rome, Polo Pontino, Latina, Italy; 2NEMA Research Inc., Naples, FL, USACorrespondence: Flaminia ColuzziDepartment of Medical and Surgical Sciences and Bi...

Full description

Bibliographic Details
Main Authors:	Coluzzi F, Scerpa MS, Pergolizzi J
Format:	Article
Language:	English
Published:	Dove Medical Press 2020-05-01
Series:	Journal of Pain Research
Subjects:	pamoras opioid-induced constipation naldemedine opioid-induced bowel dysfunction analgesia chronic pain
Online Access:	https://www.dovepress.com/naldemedine-a-new-option-for-oibd-peer-reviewed-article-JPR

Similar Items

Spotlight on naldemedine in the treatment of opioid-induced constipation in adult patients with chronic noncancer pain: design, development, and place in therapy
by: Stern EK, et al.
Published: (2018-01-01)

A Systematic Review of Naldemedine and Naloxegol for the Treatment of Opioid-Induced Constipation in Cancer Patients
by: Ursula K. Braun, et al.
Published: (2024-03-01)

Naldemedine in Japanese patients with opioid-induced constipation and chronic noncancer pain: open-label Phase III studies
by: Saito Y, et al.
Published: (2018-12-01)

Rationale and design of a multicenter, double-blinded, randomized, placebo-controlled trial to investigate the effects of naldemedine on opioid-induced constipation for patients with cancer pain: A study protocol
by: Takahiro Higashibata, et al.
Published: (2022-10-01)

A Nationwide Hospital Claims Database Analysis of Real-World Patterns of Laxative Use for Opioid-Induced Constipation in Japanese Patients with Cancer
by: Takahiro Higashibata, et al.
Published: (2023-05-01)

A Renal Impairment Subgroup Analysis of the Safety and Efficacy of Naldemedine for the Treatment of Opioid-Induced Constipation in Patients with Chronic Non-Cancer Pain Receiving Opioid Therapy
by: Webster LR, et al.
Published: (2020-03-01)

A retrospective study of the efficacy and safety of naldemedine for opioid‐induced constipation in thoracic cancer patients
by: Hisao Imai, et al.
Published: (2022-08-01)

Prevention and management of diarrhea associated with naldemedine among patients receiving opioids: a retrospective cohort study
by: Yusuke Takagi, et al.
Published: (2020-01-01)

Comparing the effectiveness of magnesium oxide and naldemedine in preventing opioid-induced constipation: a proof of concept, single institutional, two arm, open-label, phase II, randomized controlled trial: the MAGNET study
by: Anna Ozaki, et al.
Published: (2020-06-01)

Opioids and Immunosuppression: Clinical Evidence, Mechanisms of Action, and Potential Therapies
by: Jeffrey J. Bettinger, et al.
Published: (2024-02-01)

Naloxegol in opioid-induced constipation: a new paradigm in the treatment of a common problem
by: Yoon SC, et al.
Published: (2017-07-01)

Real-World Patient Characteristics and Treatment Patterns of Naldemedine for the Treatment of Opioid-Induced Constipation in Patients with Cancer: A Multicenter Retrospective Chart Review Study
by: Eriko Hiruta, et al.
Published: (2021-11-01)

A Retrospective Study of the Efficacy and Safety of Naldemedine for Treatment of Opioid-Induced Constipation in Patients with Hepatobiliary Pancreatic Cancer
by: Teruhiko Kamiya, et al.
Published: (2023-03-01)

The Use of Peripheral μ-Opioid Receptor Antagonists (PAMORA) in the Management of Opioid-Induced Constipation: An Update on Their Efficacy and Safety
by: Pergolizzi JV Jr, et al.
Published: (2020-03-01)

Naldemedine-induced perforation of a diverticulum in the sigmoid colon of a patient with opioid-related constipation: a case report
by: Hayato Yokota, et al.
Published: (2024-08-01)

Safe Use of Opioids in Chronic Kidney Disease and Hemodialysis Patients: Tips and Tricks for Non-Pain Specialists
by: Coluzzi F, et al.
Published: (2020-09-01)

Methylnaltrexone Treatment for Opioid-Induced Constipation in Patients with and without Cancer: Effect of Initial Dose
by: Chamberlain BH, et al.
Published: (2023-07-01)

Opioid-induced bowel dysfunction: a literature review
by: Urszula Żurek, et al.
Published: (2023-07-01)

Common Clinical Practice for Opioid-Induced Constipation: A Physician Survey
by: Coluzzi F, et al.
Published: (2021-07-01)

Incidence of opioid‐induced constipation in Japanese patients with cancer pain: A prospective observational cohort study
by: Akihiro Tokoro, et al.
Published: (2019-08-01)

The Efficacy of Lubiprostone in Patients of Constipation: An Updated Systematic Review and Meta‐Analysis
by: Umar Akram, et al.
Published: (2025-01-01)

Patient and provider differences in the treatment of opioid-induced constipation: a qualitative study
by: Michelle S. Keller, et al.
Published: (2019-11-01)

Addressing opioid tolerance and opioid‐induced hypersensitivity: Recent developments and future therapeutic strategies
by: Faris Khan, et al.
Published: (2021-05-01)

Subcutaneous Methylnaltrexone as Treatment for Opioid-Induced Constipation in Patients with Advanced Cancer and Noncancer Illnesses: A Post Hoc Analysis of Two Clinical Trials
by: Shah ED, et al.
Published: (2023-02-01)

Subcutaneous Methylnaltrexone for Treatment of Opioid-Induced Constipation in Cancer versus Noncancer Patients: An Analysis of Efficacy and Safety Variables from Two Studies
by: Chamberlain BH, et al.
Published: (2021-09-01)

Oral methylnaltrexone is efficacious and well tolerated for the treatment of opioid-induced constipation in patients with chronic noncancer pain receiving concomitant methadone
by: Webster LR, et al.
Published: (2018-10-01)

In vitro and in vivo Pharmacological Activities of 14-O-Phenylpropyloxymorphone, a Potent Mixed Mu/Delta/Kappa-Opioid Receptor Agonist With Reduced Constipation in Mice
by: Roberta Lattanzi, et al.
Published: (2018-08-01)

What to Do and What Not to Do in the Management of Opioid-Induced Constipation: A Choosing Wisely Report
by: Domenico Alvaro, et al.
Published: (2020-09-01)

Impact of Patient Subgroups on the Efficacy and Safety of Methylnaltrexone for Opioid-Induced Constipation in Patients with Advanced Illness
by: Mehta N, et al.
Published: (2023-10-01)

Efficacy and Safety of Naloxegol in Patients with Chronic Non-Cancer Pain Who Experience Opioid-Induced Constipation: A Pooled Analysis of Two Global, Randomized Controlled Studies
by: Chey WD, et al.
Published: (2023-08-01)

Potential drug‐induced constipation: A retrospective study using a Japanese claims database
by: Yusuke Karasawa, et al.
Published: (2024-02-01)

Acupuncture Relieves Opioid-Induced Constipation in Clinical Cancer Therapy – A Meta-Analysis and Systematic Review
by: Han C, et al.
Published: (2021-10-01)

Insights into the Current and Possible Future Use of Opioid Antagonists in Relation to Opioid-Induced Constipation and Dysbiosis
by: Nariman Essmat, et al.
Published: (2023-11-01)

Cumulative Laxation Response with Methylnaltrexone: Implications for Hospitalized Patients with Advanced Illness and Opioid-Induced Constipation
by: David Farchadi, MD, MS, et al.
Published: (2023-01-01)

The Role of The Rostral Ventromedial Medulla in Stress Responses
by: Marco Pagliusi, et al.
Published: (2023-05-01)

Remifentanil-induced postoperative hyperalgesia: current perspectives on mechanisms and therapeutic strategies
by: Santonocito C, et al.
Published: (2018-04-01)

Efficacy and tolerability of low-dose oral prolonged-release oxycodone/naloxone for chronic nononcological pain in older patients
by: Guerriero F, et al.
Published: (2014-12-01)

Pain in the management of opioid use disorder
by: Sirohi S, et al.
Published: (2016-11-01)

Resource use and costs associated with opioid-induced constipation following total hip or total knee replacement surgery
by: Wittbrodt ET, et al.
Published: (2018-05-01)

Case Report: “I got my brain back” A patient’s experience with music-induced analgesia for chronic pain
by: Roberto E. Mercadillo, et al.
Published: (2023-04-01)